Clinton douses tobaccos
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.In remarks that helped to depress shares of BAT Industries in London, President Bill Clinton yesterday criticised a key provision in last month's landmark agreement between US states and the big cigarette companies.
President Clinton, speaking at the end of the Nato summit in Madrid, said he could not accept clauses in the pact that would restrict the authority of the Food and Drug Administration to set nicotine levels in cigarettes.
The statement underlined the fragility of the 20 June pact, under which the tobacco companies agreed to pay out $368bn (pounds 218bn) for compensation payments and for anti-smoking campaigns over 25 years in return for protection from future litigation and for curbs on the FDA's power.
As negotiations on passing the agreement into law get started, it is also becoming clear that the recent turbulence for tobacco stocks is far from over. In London, BAT shares shed 12p at 536.5p.
Negotiating the agreement, the tobacco giants won provisions insisting the FDA should not outlaw nicotine in cigarettes for at least another 12 years. Before attempting to lower levels, the FDA would have to demonstrate it would not create a black-market.
Calling the provision an "unreasonable restriction", the President said he was confident that removing it from the pact would not prompt the tobacco firms to withdraw.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments